European Parliament call for premarket approval is not a done deal, says Eucomed's Brennan
This article was originally published in Clinica
Executive Summary
The EU medtech sector should be taking a measured view of the European Parliament’s stance on how the regulatory system needs to be improved and that the so-called "PIP resolution" which it recently passed represent more a snapshot of Parliament's current views, rather than its final position.